State of the art in tailoring antithrombotics according to bleeding risk.

Back

ESC Premium Access

State of the art in tailoring antithrombotics according to bleeding risk.

Session: Tailoring antithrombotics according to bleeding risk

Topic: Thrombosis and coagulation

Speaker: Professor F. Andreotti (Rome, IT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Felicita Andreotti

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

28 presentations

7 followers

4 more presentations in this session

Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program

Speaker: Professor M. Huisman (Leiden, NL)

Impact of previous exposure to oral anticoagulants on the risk of death or rehospitalization in patients with acute coronary syndrome - analysis according to the anticipated risk of bleeding.

Speaker: Doctor C. Ruivo (Leiria, PT)

Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events

Speaker: Doctor G. Lemesle (Lille, FR)

Future direction for research in tailoring according to bleeding risk.

Speaker: Professor R. De Caterina (Pisa, IT)

Access

Slides

Video

Access the full session

Tailoring antithrombotics according to bleeding risk

Speakers: Professor F. Andreotti, Professor M. Huisman, Doctor C. Ruivo, Doctor G. Lemesle, Professor R. De Caterina

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources